CIK 0001645469
- Non-accelerated filer
- Smaller reporting company
Monopar Therapeutics
Sign in to watch- Ticker
- MNPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320463781
- Phone
- +1 847-388-0349
- Business address
- 1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,335,315
- in 9 filings, $5.3M under 10b5-1 plans
Net −$5,335,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 27 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-20 | Robinson Chandler Chief Executive Officer | Shares withheld for taxes | −597 | $92.59 | $55K | 104,127 |
| 2026-09-30 | Robinson Chandler Chief Executive Officer | Option exercise | +9,801 | 109,068 | ||
| 2026-09-30 | Robinson Chandler Chief Executive Officer | Shares withheld for taxes | −4,344 | $79.67 | $346K | 104,724 |
| 2026-09-30 | Robinson Chandler Chief Executive Officer | Option exercise · Restricted Stock Unit | −9,801 | 83,602 | ||
| 2026-09-24 | Robinson Chandler Chief Executive Officer | Option exercise 10b5-1 | +14,056 | $30.00 | $422K | 113,323 |
| 2026-09-24 | Robinson Chandler Chief Executive Officer | Option exercise 10b5-1 | +15,000 | $14.00 | $210K | 128,323 |
| 2026-09-24 | Robinson Chandler Chief Executive Officer | Sale 10b5-1 | −10,450 | $87.15 | $911K | 117,873 |
| 2026-09-24 | Robinson Chandler Chief Executive Officer | Sale 10b5-1 | −9,638 | $87.96 | $848K | 108,235 |
| 2026-09-24 | Robinson Chandler Chief Executive Officer | Sale 10b5-1 | −8,368 | $88.97 | $745K | 99,867 |
| 2026-09-24 | Robinson Chandler Chief Executive Officer | Sale 10b5-1 | −600 | $89.79 | $54K | 99,267 |
| 2026-09-24 | Robinson Chandler Chief Executive Officer | Option exercise · Stock Option 10b5-1 | −14,056 | 15,044 | ||
| 2026-09-24 | Robinson Chandler Chief Executive Officer | Option exercise · Stock Option 10b5-1 | −15,000 | 27,204 | ||
| 2026-06-30 | Robinson Chandler Chief Executive Officer | Option exercise | +12,873 | 103,351 | ||
| 2026-06-30 | Robinson Chandler Chief Executive Officer | Shares withheld for taxes | −4,084 | $92.59 | $378K | 99,267 |
| 2026-06-30 | Robinson Chandler Chief Executive Officer | Option exercise · Restricted Stock Unit | −12,873 | 93,403 | ||
| 2026-03-31 | Robinson Chandler Chief Executive Officer | Option exercise | +6,732 | 92,450 | ||
| 2026-03-31 | Robinson Chandler Chief Executive Officer | Shares withheld for taxes | −1,972 | $54.79 | $108K | 90,478 |
| 2026-03-31 | Robinson Chandler Chief Executive Officer | Option exercise · Restricted Stock Unit | −6,732 | 106,276 | ||
| 2025-12-31 | Robinson Chandler Chief Executive Officer | Option exercise | +8,724 | 88,276 | ||
| 2025-12-31 | Robinson Chandler Chief Executive Officer | Shares withheld for taxes | −2,558 | $65.30 | $167K | 85,718 |
Page 1 of 6 · 106 trades